Giddy’s Breakthrough Medical Device, “Eddie,” On Course to Transform Sexual Health & Wellness Sector

Austin, TX — Giddy’s launch of “Eddie,” a utility patented, FDA-Registered Class II Medical Device for erectile dysfunction (ED); is the first release from Giddy’s innovative line of products and interactive educational platforms disrupting the sexual health and wellness sector.

Most men and couples have experienced ED, but few ever talk about it. The most complete study of ED released in 2017 (ED Study) revealed that 40% of men over the age of 18 experience ED; over 47.5MM men in the US alone. There are 28 million women and 4 million men currently in a relationship with someone experiencing ED. And, 90% of women with more than 3 sexual partners in their lifetime will be in a relationship with someone with ED. Despite the astounding prevalence of the problem, and the consequences to individuals and their relationships, the ED sector has seen little to no innovation.

Studies have shown that ED is the primary reason for breakups and divorce behind finance; and while the perception is that prescription drugs like Viagra and Cialis solve every man’s problem, these kinds of drugs weren’t even originally created to treat ED, and in fact are consumed by less than 5% of ED sufferers. Data suggests these medications aren’t much more effective than constriction devices and vacuum pumps, which have gone largely unchanged for hundreds of years. As a result of limited options, 70 to 80% of men with ED don’t utilize any treatment method.

After 3 years of research and development, Giddy has brought to market Eddie; a groundbreaking product designed by urologists, engineers, and mathematicians created specifically to promote penile rigidity in men with ED. The device’s utility patented, dynamic tension system is the first of its kind; designed to help sustain blood flow into the penis without constricting the arteries or the urethra like traditional constriction rings.

While companies like Hims and Roman are spending hundreds of millions of dollars to combat the stigma associated with this common problem (and open up the topic of ED for conversation), their solution is nothing new; it’s the repackaging and selling of overpriced generic ED pills.

Giddy is taking a different approach. Giddy is taking the lead and creating a meaningful and long term option for ED sufferers and their partners to improve their sex lives and performance. Without any requirement for a prescription, Giddy not only empowers men; it empowers the partners of those with ED to make a buying decision which can positively affect their partner’s ED and take agency over their relationship and sexual health and wellness. All this for $99; less expensive than any other ED option on an annualized basis.

Hims recently raised $100MM at a $1.1B valuation and is seeking to raise a rumored $250MM at a $2B valuation, while Roman has raised over $100MM with a greater than $1B valuation. Giddy has backing from several notable angel investors, VCs and family offices, and is planning a Series A in the coming months. After record-breaking presale figures on the Indiegogo crowdfunding platform which generated almost $300k in the limited trafficked “After Dark” section of Indiegogo; public sales officially began in October 2019. A high growth company with tremendous consumer traction and scalability is nothing new. What is novel about Giddy is that it achieved profitability in its first month of official launch, and is rapidly approaching 100K units sold in its first 6 months of sales in the US alone. Giddy is in the process of scaling production and will begin international expansion by the end of 2020.

Currently, US orders are being fulfilled within 1 business day, with customers receiving delivery within 7 to 10 days of purchase with expedited options also available for an additional fee. Customer reviews are flooding into Giddy with stories of not only the product working, but also about how it’s changing customers’ relationships with their loved ones. Some of Giddy’s several thousand reviews can be found here.

Every Eddie by Giddy includes access to an online, interactive educational platform called the ED Guide. All men with ED exist somewhere on the spectrum of completely psychological to completely physiological causes; Giddy’s ED Guide intends to address all the possible root causes. Giddy is the first company to take this multi-faceted approach incorporating a wearable medical device and online educational resource; providing millions of men and their partners an opportunity to improve their ED for the very first time.

The ED Guide features testimony and information from experts in health and wellness, designed to improve the mental and emotional aspects of ED. Users can select video topics relevant to them; topics like dating with ED, medications that cause ED, ED brought on by PTSD, re-establishing intimacy, improving communication, and many others. Or, users may take a Baseline Assessment about their lifestyle, medical history, ED symptoms and other factors which will identify 1 of 88 possible curriculums designed by Giddy to provide the education and exercises to address their ED directly. As of January 2020, Giddy reports that more than 55% of customers have utilized its online, interactive educational resource. To watch the trailer video for the ED Guide, click here.

Giddy’s commitment to sexual health and wellness extends beyond offering a breakthrough device; to date Giddy has donated over $40K to prostate cancer research and treatment via organizations such as Zero and MaleCare.

About Giddy

Giddy is a leader in the sexual health and wellness sector. We’re dedicated to improving the lives of men and their partners of all lifestyles with our line of innovative medical products and information, starting with our flagship product, an FDA Registered Class II Medical device called “Eddie,” and our online, interactive educational resource called the ED Guide.

Headquartered in Austin, Texas, Giddy’s team includes top engineers, mathematicians, urologists, experienced entrepreneurs with proven track records, and medical device executives from companies like Johnson & Johnson to drive growth in the US and abroad.

For media inquiries please contact Brian Gross, BSG PR, (818) 340-4422. [email protected].